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Neomycin is an aminoglycoside antibiotic that
is produced naturally by the actinomycete bacterium
Streptomyces fradiae via the fermentation process. It
has bactericidal properties against Gram negative
bacteria and partial also against Gram positive bac-
teria. Neomycin in a sulfate form is a common
aminoglycoside indicated for treatment of gastroin-
testinal infections. Neomycin sulfate is mainly com-
posed of the two isometric components neomycins
B and C. The component B has higher antibiotic
activity than component C (1). Neomycin is mostly
administered in the form of powder, aerosols,
creams and also drops and ointments often in com-
plex preparations with bacitracin, dexamethasone,
polymyxin, gramicidin, hydrocortisone, fluoci-
nolone, etc. (2, 3, 4).
There are several methods described for the
determination of neomycin in pharmaceutical prepa-
rations: colorimetric determination (5), fluorimetric
determination (6), near-infrared spectroscopy (7)
and spectrophotometric determination (8, 9). Some
of the most popular methods are chromatographic
methods: liquid chromatography with varied meth-
ods of detection like HPLC-PED (pulsed electro-
chemical detection) (10, 11), HPLC-ELSD
(Evaporative Light Scatering Detection) (12),
HPAE-IPAD (High-performance anion-exchange
chromatography with integrated pulsed amperomet-
ric detection) (13) and thin layer chromatography
(14, 15).
Pendela et al. described the analysis of ear drops
containing neomycin sulfate, polymyxin B sulfate
and dexamethasone sodium phosphate using liquid
chromatography with pulsed electrochemical detec-
tion on a gold electrode (10). The similar study was
performed to a formulation, which contained
neomycin sulfate, polymyxin B sulfate and grami-
cidin (11). HPLC-ELSD method was applied suc-
cessfully for the determination of neomycin and sul-
fate in raw materials, pharmaceutical formulations
(powder, aerosols and creams) and medicated animal
feeds (12). HPAE-IPAD was used to determine
neomycin B and its impurities. The method was
shown to be rugged for the intended application of
neomycin identity, purity and assay (13). A thin layer
chromatography with densitometric detection for
simultaneous identification and quantitative determi-
nation of neomycin sulfate, polymyxin B sulfate, zinc
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bacitracin and methyl and propyl hydroxybenzoate in
ophthalmic ointment was described by Krzek et al.
(14). Hubicka et al. described the analysis of
amikacin, gentamicin, kanamicin, neomycin,
netilmycin and tobramycin in pharmaceutical prepa-
rations (tobramycin ampoules, amikacin vials, tablets
containing 250 mg of neomycin and eye drops con-
taining 3 mg/mL of gentamicin) (15). The densito-
metric measurements were made after detection with
a 0.2% ninhydrin solution in ethanol (14, 15).
Anionic capillary isotachophoresis (cITP) with
conductometric detection was used for indirect
determination of neomycin trisulfate as sulfate anion
in pharmaceutical preparations (16, 17). Capillary
elektrophoresis with direct (18) and indirect (19, 20)
UV detection for simultaneous determination of
neomycin sulfate and such active substances as
hydrocortisone, polymyxin in various pharmaceuti-
cal preparations have been reported (18ñ20).
Since 1975, dabsyl chloride (DBS) has been
used for identification of N-terminal amino acid in
polypeptide chain during analysis of compounds
containing amine group (21). The first step in the
process is condensation of DBS with polypeptide
through N-terminal amino acid. The second step is
hydrolysis in acidic environment that results in a
product ñ sulfonamide derivative. The final third
step is chromatographic identification of obtained
product. This reaction is highly sensitive (10-9ñ10-10
mol/L). For example, biogenic amines, bisoprolol,
labetalol, and propafenone as dabsyl derivatives
were determined (22ñ25).
The quantitative determination of bacitracin
after condensation reaction with DBS was presented
by Krzek and Piotrowska. Modification in the
method of N-terminal amino acid determination
with the use of DBS was done by exclusion of
hydrolysis and establishing reaction conditions to
enable direct spectrophotometric estimation of the
product of DBS reaction with the antibiotic (26).
In this paper a new TLCñdensitometric method
was developed for the simultaneous identification
and quantitative determination of neomycin deriva-
tive with dabsyl chloride (NDC), directly without
the requirement of chromatogram visualization. The
developed method was validated and used for the
quantitative determination of neomycin in pharma-
ceutical preparation.
EXPERIMENTAL
Reagents
Acetone, sodium carbonate, sodium bicarbon-
ate, 25% ammonia, butanol, 2-butanone were of
analytical grade and were purchased either from
POCh (Gliwice, Poland) or Chempur (Piekary
ålπskie, Poland). 
Dabsyl chloride (DBS) ñ assay = 97.5% (AT)
no. 39068 (Fluka, Chemie AG Buchs, Switzerland).
Solutions of DBS in acetone were prepared at con-
centrations 0.3238 mg/mL and 0.1619 mg/mL.
Standard solutions and substance
The following pharmaceutical raw material of
neomycin sulfate was used: 25 g PPH Galfarm ñ no.
011209. Neomycin met the requirements described
in a monograph in Polish Pharmacopoeia (FP VIII)
within the scope of identity, purity and biological
activity. Standard solutions in water were prepared
at concentrations from 1.8603 to 0.1970 mg/mL cal-
culated on neomycin.
Pharmaceutical preparation and solution
Neomycinum ñ tablets (250 mg neomycin sul-
fate, macrogol 4000, sodium starch glycolate type
A, talc, magnesium stearate, saccharose about 260
mg in one tablet). Polfa Tarchomin S.A., Poland,
series No. 1010904. 
A solutions of Neomycinum ñ to prepare sam-
ple solution from powdered mass of 20 tablets,
50.10 mg corresponding to 15.52 mg of neomycin
was accurately weighed. Then, 15.0 mL of water
was added into the sample and the solution was
shaken for 15 min. Then, the solution was filled up
with water to 25.0 mL. The suspension was filtered
directly into a 25.0 mL volumetric flask through
qualitative filter paper. For testing by spectrophoto-
metric method, the solution of neomycin at a con-
centration of 1.8600 mg/mL was prepared similarly.
TLC method
Preparation of neomycin derivative with dabsyl
chloride (NDC)
A product of reaction was formed when 0.5 mL
of neomycin solution was mixed with 1.0 mL of
DBS (0.1619 mg/mL) and 0.2 mL of carbonate
buffer (pH = 9.0). The samples and blank solution
were heated up in water bath at 70OC for 15 min, and
then cooled down and adjusted with acetone to the
final volume of 5.0 mL. A blank solution containing
identical volume of carbonate buffer (pH = 9.00)
and DBS concentration as in the study sample was
prepared.
TLC analysis
TLC was performed on 10 ◊ 12 cm TLC plates
cut from 20 ◊ 20 cm aluminium foil-backed plates pre-
coated with silica gel 60 F254 (Merck, Germany;
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#1.05548). Solutions of the NDC obtained for standard
solutions and for preparation solution (30 µL) were
applied to the plates as 0.8 cm bands, 1.0 cm from the
bottom edge, 1.0 cm from the sides and 0.8 cm apart,
by use of a Linomat V sample applicator (Camag,
Switzerland). Chromatograms were developed to a dis-
tance of 12 cm with n-butanol ñ 2-butanone ñ 25%
ammonia ñ water (10 : 6 : 2 : 2, v/v/v/v) as a mobile
phase in a chromatographic chamber (18 ◊ 9 ◊ 18 cm
Sigma-Aldrich, USA, #Z20,415-3). The mobile phase
was chosen experimentally by checking different sol-
vent mixtures. Plates were dried at room temperature
for one hour. Bands on the chromatograms retain
durable yellow color within 24 h. Color of bands con-
trasts with a white background of chromatogram.
Bands were visible and could be used for quantitative
densitometric determination. Detection was carried out
by Camag TLC Scanner 3 with winCats 1.3.4 software
at λ = 460 nm; this wavelength was selected on the
basis of the recorded absorption spectra. In addition to
the RF values, identification of analyzed substances
were done. Peak areas of NDC obtained for standard
solutions and for preparation solution were recorded
directly from the chromatograms and were used for
quantitative analysis.
Method validation
The method was validated by checking the
specificity, linearity, precision, recovery, limits of
detection and quantification and also robustness in
accordance with ICH guidelines (27).
Specificity
Specificity of the method was assessed by
comparing chromatograms of NDC obtained for
standard solutions and for preparation solution,
chromatogram of blank solution and blank chro-
matogram.
In obtained chromatograms, the retardation
factor (RF) values of analyzed substances, resolution
factor, peak areas, peak purity and spot color were
taken into account. Resolution factor (Rs) was cal-
culated according to the formula: 
Rs = 2 ◊ (distance between the centers of two
adjacent spots) / (sum of the two spots in the direc-
tion of development). 
Linearity
The calibration plot for the method was con-
structed by analysis of seven solutions containing
different concentrations of neomycin in the range
0.1970 ñ 0.7320 mg/mL after reaction with dabsyl
chloride. Preparation of samples working solutions
were described before. Further analytical procedure
was described in ìTLC analysisî. Linearity was
assessed in triplicate on the basis of the relationship
between mean peak area and amount of neomycin in
micrograms per band. Linearity was reported as
regression equations, correlation coefficients (r) and
determination coefficient (r2).
The limit of detection (LOD) and quantification
(LOQ)
Solutions of neomycin in the form of derivative
with DBS (0.1220 ñ 0.3660 mg/mL) were applied on
the plates. LOD and LOQ were calculated on the
basis of the slope (a) of the calibration line and the
standard error of the estimate (Se), using formulas: 
LOD = 3.3 Se / a and LOQ = 10 Se / a.
Precision
The repeatability of the method was deter-
mined by analysis of five replicates of NDC
obtained for standard solutions from individual
weighings. Study was done for three concentration
levels, 50% (0.5918 µg per band of NDC), 100%
(1.0980 µg per band of NDC) and 150% (1.6470 µg
per band of NDC). Intermediate precision was
obtained by analysis of solutions at the same con-
centration by a different analyst who performed the
analysis over a period of one week. 
Accuracy 
Accuracy was assessed by determination of the
recovery (%) of the drug. Precisely known weighed
amounts of the neomycin standard (from 80 to 120%
of the declared content) were added to preparation
solutions and percentage recovery was calculated on
the basis of the determined amounts of added
neomycin standard under conditions of developed
method in relation to the amount weighed. For each
level three determinations were done.
Robustness
Under conditions of the developed method,
comparison of results with change of stationary
phase from TLC (Merck, Germany) to TLC (poly-
ester sheets precoated with silica gel 60 F254
Macherey-Nagel, Germany; #805023) plates was
done.
The impact of small changes of 25% ammonia
in the composition of the mobile phase (± 5%) for
chromatographic separation was checked.
Determination of neomycin in pharmaceutical
preparation
Determination of neomycin in tested tablets
was carried out according to earlier described proce-
34 URSZULA HUBICKA et al.
dure. The amount of 0.9150 µg per band of NDC
obtained for standard solution and preparation solu-
tion were applied onto TLC plates for the determi-
nation of neomycin content. For each determination
three measurements were performed and the mean
value was taken for calculations.
Spectrophotometric method
In order to compare the test results obtained by
TLC method for the determination of neomycin,
spectrophotometric method was performed (26).
The method was validated in accordance with ICH
guidelines (27). The obtained results were used for
statistical evaluation.
Formation of neomycin derivative with dabsyl chlo-
ride
A product of reaction was formed when 0.2 mL
of neomycin solution (0.6100 mg/mL) in water was
mixed with 1.2 mL of DBS solution (0.3238 mg/mL)
and 0.2 mL of carbonate buffer (pH = 9.0), heated up
at 70OC for 15 min, then cooled down to 25OC, 0.5
mL of distilled water added and adjusted with ace-
tone to the final volume of 5.0 mL. A reference mate-
rial containing identical volume of carbonate buffer
(pH = 9.00) and DBS concentration as in the studied
sample was prepared for each individual sample.
Absorbance at 492 nm was measured by use of a
UV/Vis spectrophotometer (Varian Cary 100 Conc.)
in relation to appropriate reference material.
Determination of neomycin in pharmaceutical
preparation
Determination of neomycin in tested tablets
after formation of neomycin derivative with dabsyl
chloride was carried out according to earlier
described procedure. For this purpose, a series of
six solutions containing DBS with neomycin
preparation solution at a concentration of 1.8600
mg/mL were prepared. Then, the content of
neomycin in pharmaceutical preparation was cal-
culated by comparing appropriate values of
absorbance recorded at λmax = 492 nm for standard
and sample solutions. 
RESULTS AND DISCUSSION 
Reaction of free amine groups with DBS was
used for the development of a new TLC method for
the determination of neomycin in pharmaceutical
preparation. In the first stage of studies, conditions
for the separation of NDC and DBS were estab-
lished (Fig. 1).
The mobile phase n-butanol ñ 2-butanone ñ
25% ammonia ñ water (10 : 6 : 2 : 2, v/v/v/v)
enables good resolution of analyzed substances.
NDC on TLC chromatogram appeared as a compact
yellow band, which contrasts with the white back-
ground of the plate and its RF value was 0.22. The
NDC bands were stable after application to the plate
for 24 h. Next to the NDC, band of DBS (RF  0.53)
appeared in chromatogram and didnít interfere with
the band of tested complex (Fig. 2).
The application of densitometric detection
demonstrated that peaks in the chromatograms were
well resolved, symmetrical and easy to identify and
determine. Registration of peak areas for NDC was
carried out at λ = 460 nm. The analytical wavelength
chosen for densitometric registration corresponded
to absorption maximum for NDC.
Figure 1. Scheme of synthesis of neomycin derivative
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In the available literature there were some
papers describing the determination of neomycin by
thin-layer chromatography, where densitometric
detection of neomycin was performed after previ-
ously spraying with a ninhydrin solution (14, 15).
Application of ninhydrin required complete evapo-
ration of ammonia (mobile phase component) from
the stationary phase by heating plates at 100OC for
about 1.5 h. The research presented in this paper
revealed that the developed method for the determi-
nation of neomycin in the form of color derivative
with DBS may be an alternative to time consuming
method using ninhydrin solution for the visualiza-
tion of chromatograms. 
For estimation of reliability of the developed
method according to ICH recommendations, the fol-
lowing parameters were determined: specificity, lin-
earity, limits of detection and quantitation, recovery
and robustness (27).
The developed method was specific against the
studied components. There are no peaks in chro-
matogram recorded for blank solution, chro-
matograms of NDC obtained for standard solutions
and for preparation solution and blank chro-
matogram where studied components occur. Good
correlation between VIS spectra acquired from the
standard and the pharmaceutical preparation indicat-
ed that NDC spot was free of any interference that
Figure 2. Densitogram of neomycin derivative with dabsyl chloride (NDC) and dabsyl chloride (DBS)
Figure 3. Linear relationship between peak area and concentration of NDC.
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might be present in the analysis. Resolution of the
peaks appearing in the chromatograms was 3.94. 
A plot of concentration against mean peak area
of NDC was linear over the range from 0.5918 µg
per band to 2.1960 µg per band. The correlation
coefficient (r) and determination coefficient (r2)
obtained for significance level 0.05 and n = 7 were
close to 0.99 that proved a highly significant linear
correlation (Fig. 3). The y-intercept of the linear
equation for NDC was statistically insignificant.
The regression equation of the calibration plot, val-
ues of standard deviation of the slope (Sa), standard
deviation of the intercept (Sb) and standard error of
the estimate (Se) are presented in Table 1. 
Based on parameters of the curve (P = ñ25.48
+ 650.27C, r = 0.9846 and Se = 38.48), in low range
of concentrations, the LOD and LOQ (µg per band)
values were 0.1953 and 0.5918, respectively. These
low values indicated satisfactory sensitivity of the
method. 
Table 1. The results of validation of TLC and spectrophotometric method.
Parameter TLC ñ densitometry VIS spectrophotometry 
RF 0.20 ± 0.03 ñ
Limit of detection 0.1953 µg per band 1.48∑10-3 mg/mL
Limit of quantitation 0.59 µg per band 4.48∑10-3 mg/mL
Linearity range 0.59 ñ 2.20 µg per band 4.48∑10-3 ñ 2.46∑10-2 mg/mL
Regression coefficients a = 534.28 a = 23.673
P = a c + b ± Se b = 69.667 ± 55.29 b = ñ0.0357 ± 0.01679
Standard deviation of the Sa = 37.52 Sa = 0.709
regression coefficients Sb = 51.51 Sb = 0.0106
Correlation coefficient, r r = 0.9879 r = 0.9969
Determination coefficient r2 r2 = 0.9759 r2 = 0.9938
Precision n = 5
level 50%: xm = 263.68 RSD = 1.70% xm = 95.94% RSD = 2.92%
level 100%: xm = 637.84 RSD = 1.44% xm = 96.75% RSD = 2.23%
level 150%: xm = 1026.26 RSD = 1.17% xm = 103.26% RSD = 1.89%
Intermediate precision n = 5
level 50%: xm =228.10 RSD = 2.05% xm = 100.22% RSD = 3.38%
level 100%: xm =743.42 RSD = 2.01% xm = 99.98% RSD = 3.30%
level 150%: xm =1062.44 RSD = 1.27% xm = 99.60% RSD = 2.04%
Recovery, (%) n = 3
level 80%: 101.48% RSD = 2.65% 105.31% RSD = 0.89%
level 100%: 101.26% RSD = 2.07% 97.29% RSD = 2.11%
level 120%: 100.97% RSD= 2.40% 97.75% RSD = 1.74%
P ñ peak area; c ñ concentration [µg per band]; a and b ñ regression coefficients, Se ñ standard error of the esti-
mate, Sa ñ standard deviation of the slope a, Sb ñ standard deviation of the intercept, xm ñ arithmetic mean; RSD
ñ relative standard deviation.
Table 2. The results of neomycin determination in pharmaceutical preparation with statistical evaluation.
Preparation 
Declared
Determined concentration
concentration 
TLC method
Spectrophotometric 
method
xm = 253.15 xm = 254.70
SD = 5.2908 SD = 2.5145
Neomycinum RSD = 2.09% RSD = 2.47%
(tablets)
250 mg
Fisher-Snedecor test:
Fobs = 4.43; F1-α = 5.05 for f = 5, α = 0.05
Fobs < F1-α statistically insignificant
f ñ number of degrees of freedom, α ñ significance level, SD ñ standard deviation, RSD ñ relative standard deviation, Fobs ñ calculated
experimental value; F1-α ñ critical value from the Snedecor law table.
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Accuracy of the method expressed as % recov-
ery at three concentration levels was from 100.97 to
101.48%. Good precision and intermediate precision
with % RSD less than 2.10% was observed. Detailed
results are presented in Table 1. In all the deliberate-
ly varied chromatographic conditions (composition
of the mobile phase, change of stationary phase), the
retention parameters of NDC remained unchanged.
The usefulness of the method was examined by
determination of neomycin in the tablets. There was
no influence of additional components present in
tested preparation such as macrogol, sodium starch
glycolate type A, talc, magnesium stearate, sucrose
and the components of the substrate on the determi-
nation results. Satisfactory results of the quantitative
determination were obtained, which were character-
ized by good repeatability of measurements (RSD =
2.09%). The concentration determined by the devel-
oped method was comparable to the results obtained
by spectrophotometric method (Table 2). 
The results of determination of neomycin
obtained by TLC and spectrophotometric methods
were analyzed statistically using Fisher-Snedecor test
(Table 2). The calculated experimental value Fobs for
TLC and spectrophotometric methods were com-
pared with the critical value: F1-α (for f = 5, α = 0.05),
extracted from the Snedecor law table. Based on the
results of statistical analysis (Fobs > F1-α) it was found
that the compared methods were not different consid-
ering precision in statistically significant way.
CONCLUSIONS
In reaction of neomycin with DBS a yellow
complex of neomycin derivative was formed which
can be used in direct TLCñdensitometric analysis at
λ = 460 nm.
The method meets the acceptance criteria for
validation and may be useful for the determination
of neomycin in the form of derivative with DBS in
pharmaceutical products.
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